Loading clinical trials...
Loading clinical trials...
This study aims to investigate the chronic effects of ETAS® on cognitive, affective and neural outcomes in healthy adults aged 60-80 years with mild to moderate subjective cognitive complaints.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Reading
Collaborators
NCT05052216 · Pediatric Obstructive Sleep Apnea
NCT06109363 · Insomnia, Sleep Disturbance
NCT07082218 · Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury, and more
NCT07225686 · Obesity, Obstructive Sleep Apnea
NCT07047092 · Chronic Obstructive Pulmonary Disease Exacerbation, Obstructive Sleep Apnea Exacerbation
University of Reading, School of Psychology and Clinical Languages
Reading, Berkshire
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions